Načítá se...
In Vivo Selection of Rifamycin-Resistant Clostridium difficile during Rifaximin Therapy
We report the selection of Clostridium difficile resistant to the rifamycin class of antibiotics in a patient within 32 h of receiving rifaximin for the treatment of recurrent C. difficile diarrhea. Resistance was associated with single nucleotide substitutions within rpoB.
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3486587/ https://ncbi.nlm.nih.gov/pubmed/22908175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00974-12 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|